The U.S. Office of Research and Development awarded a $216,000 firm fixed-price purchase order to Lifenet Health for the preparation and delivery of human thyroid epithelial cells, with performance in Virginia Beach, Virginia. The contract, which commenced on November 17, 2020, includes a base year plus four option years with an ultimate completion date of November 17, 2025. This procurement supported the government's research and development initiatives by securing specialized cellular materials essential for biomedical research and therapeutic development. No set-aside designation was applied to this competitive award.
Lifenet Health, a Virginia Beach-based non-profit manufacturer of regenerative medicine products, is well-positioned as a supplier of specialized biological materials to federal agencies. The company specializes in the recovery, preservation, and distribution of human tissues and cellular therapies, and has established relationships across multiple government departments including the Department of Veterans Affairs, National Institutes of Health, Defense Health Agency, and others. Lifenet Health operates under multiple significant blanket purchase agreements, including a $5 million agreement with the Department of the Army Medical Command and a $6.5 million agreement with the Defense Health Agency, demonstrating its critical role in federal medical supply chains and its proven capability to deliver specialized biological materials to support government research and healthcare missions.